Doctor profile · Federal record

Dr. Patricia Kachur

Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Student in an Organized Health Care Education/Training Program · Pensacola, FL

  • NPI 1477947489
  • Accepts Medicare
  • 13 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
8333 N Davis Hwy
Pensacola, FL 325146050
(850) 474-8387
fax (850) 969-2891
Additional location
7552 Navarre Pkwy Unit 5
Navarre, FL 325667312

Credentials & registration

NPPES · NUCC
NPI registered
March 2015 — 11 yrs on file
Profile last updated
March 31, 2026
Year of graduation
2013 — 13 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State licenses (2)
Florida #ME133842 · Louisiana #309020

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1477947489. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
53,063
Distinct HCPCS
10
Medicare allowed
$1,405,354
HCPCS Description Services Patients Avg allowed
J1602 Injection, golimumab, 1 mg, for intravenous use 26,659 31 $13
J0897 Injection, denosumab, 1 mg 13,320 136 $23
J1745 Injection, infliximab, excludes biosimilar, 10 mg 5,780 18 $33
J9312 Injection, rituximab, 10 mg 3,500 12 $80
99214 Established patient office or other outpatient visit, 30-39 minutes 1,475 678 $125
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 386 41 $1
96372 Injection of drug or substance under skin or into muscle 287 161 $14
76881 Complete ultrasound scan of joint 258 78 $12
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 240 72 $61
96413 Administration of chemotherapy into vein, 1 hour or less 234 42 $123

In context: peer comparison

Among 6 peers in Pensacola Rheumatology Physician, average services per provider: 4,300. This provider delivers 12× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,268
Transactions
163
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 29 $1,038.16
Amgen INC. 27 $616.23
Novartis Pharmaceuticals Corporation 20 $411.27
Janssen Biotech, INC. 12 $308.47
GlaxoSmithKline, LLC. 10 $223.47
AstraZeneca Pharmaceuticals Lp 12 $203.17
Mallinckrodt Hospital Products INC. 5 $153.16
Ucb, INC. 8 $152.38
Boehringer Ingelheim Pharmaceuticals, INC. 9 $148.49
Aurinia Pharma U.S., INC. 5 $137.30
Lilly USA, LLC 7 $134.18
Radius Health, INC. 6 $124.17
Genzyme Corporation 4 $120.80
Pfizer INC. 6 $115.07
Octapharma USA, INC. 3 $58.43

By nature of payment

Food and Beverage
$3,788
Consulting Fee
$425
Education
$55

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,674
Patients
568
Total drug cost
$376,281
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 251 79 $25,073
Methotrexate (Methotrexate Sodium) Brand 242 70 $12,778
Prednisone Generic 238 107 $2,395
Tramadol Hcl Generic 210 64 $4,058
Gabapentin Generic 150 53 $4,750
Meloxicam Generic 114 39 $1,544
Celecoxib Generic 91 35 $9,473
Allopurinol Generic 70 23 $1,436
Tizanidine Hcl Generic 53 25 $937
Vitamin D2 (Ergocalciferol (Vitamin D2)) Brand 47 16 $297

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Patricia Kachur's medical specialty?
Dr. Patricia Kachur practices Rheumatology Physician in Pensacola, FL.
Where does Dr. Patricia Kachur practice?
Dr. Patricia Kachur practices at 8333 N Davis Hwy, Pensacola, FL 325146050. Office phone: 8504748387.
What is Dr. Patricia Kachur's NPI?
Dr. Patricia Kachur's National Provider Identifier (NPI) is 1477947489, issued by NPPES.
Does Dr. Patricia Kachur accept Medicare assignment?
Yes. Dr. Patricia Kachur accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Patricia Kachur commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.